{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:10:01Z","timestamp":1756375801782,"version":"3.44.0"},"reference-count":4,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,4,19]]},"abstract":"<jats:p>A 40-year-old woman with no known medical conditions or allergies presented with severely painful, watery eyes and blurred vision. She reported topical application of face-paint onto both upper eyelids prior to attending a Halloween party. She subsequently noticed a burning sensation, epiphora and misty vision within a few hours. On examination, bilateral large corneal epithelial defects were highlighted with fluorescein dye under cobalt-blue light. Antibiotic ointment, mydriatic and sodium ascorbate 10% eye-drops were given, and patient was advised to keep the eyelids shut to promote healing. No corneal defects were visible by day 4 and the patient was discharged with vision recovering to normal levels.<\/jats:p>","DOI":"10.1136\/bcr-2017-219315","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T08:54:49Z","timestamp":1494492889000},"page":"bcr-2017-219315","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateral corneal injury after face-paint application to upper eyelids"],"prefix":"10.1136","volume":"2017","author":[{"given":"Derek Kwun-hong","family":"Ho","sequence":"first","affiliation":[{"name":"Cardiff University, Cardiff, UK"},{"name":"Royal Gwent Hospital, Newport, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Ramessur","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University College London Hospitals, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Webber","sequence":"additional","affiliation":[{"name":"Royal Gwent Hospital, Newport, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"2025082802542361000_2017.may09_1.bcr-2017-219315.1","unstructured":"CTPA. CTPA \u2013 market statistics. 2015. http:\/\/www.ctpa.org.uk\/content.aspx?pageid=296 (accessed May 2017)."},{"key":"2025082802542361000_2017.may09_1.bcr-2017-219315.2","unstructured":"Regulation (EC) No 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. 2009. http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:en:PDF (accessed May 2017)."},{"key":"2025082802542361000_2017.may09_1.bcr-2017-219315.3","unstructured":"SUE Reporting Guidelines. 2012. http:\/\/ec.europa.eu\/consumers\/sectors\/cosmetics\/files\/pdf\/sue_reporting_guidelines_en.pdf (accessed May 2017)."},{"key":"2025082802542361000_2017.may09_1.bcr-2017-219315.4","unstructured":"MHRA. Yellow card scheme - MHRA. 2016. https:\/\/yellowcard.mhra.gov.uk\/ (accessed May 2017)."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-219315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:54:28Z","timestamp":1756374868000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-219315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":4,"alternative-id":["10.1136\/bcr-2017-219315"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-219315","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,5,10]]}}}